AndhraNews.net
Home » Features » Health » Coronary heart disease

Coronary heart disease


About Coronary heart disease

Popular cardiovascular therapy areas

  • Cholesterol and Triglycerides
  • Hypertension
  • Coronary Artery Disease
  • Pulmonary Arterial Hypertension
  • Atrial Fibrillation

Thrombosis Cardiovascular disease

In the developed world, its prevalence is linked to our increasingly unhealthy lifestyle, with risk factors including lack of exercise, overweight and obesity, and smoking. These are also linked to diabetes which increases the risk of developing heart disease.

Thrombosis is the general term for the formation of a blood clot in the arteries or the veins that obstructs blood flow.

Venous thrombosis, which is usually treated with anticoagulants, is the third most common cardiovascular disorder in the US, affecting almost two million people each year. The most commonly prescribed low molecular weight heparin in the US and major European markets is sanofi-aventis' Lovenox/Clexane (enoxaparin), which is derived from porcine unfractionated heparin. In 2007, sales of Lovenox increased by 7.3% to euro 2.6 billion (US$3.6 billion). Sanofi also developed Fraxiparine (nadroparin), a LMWH produced by nitrous acid degradation of heparin from porcine intestinal mucosa. Fraxiparine was acquired by GlaxoSmithKline (GSK) in 2004 in order to satisfy conditions for Sanofi-Synthélabo's merger with Aventis. In 2007, sales of Fraxiparine declined by 12.0% to £184 million (US$368 million).

Coronary heart disease in News

Diadexus, Inc. Presents New PLAC(R) Activity Data From the REGARDS Study at 2015 American Heart Association Scientific Sessions
Diadexus, Inc. (OTCQB: DDXS), a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, today announced a poster presentation at the 2015 American Heart Association (AHA) Scientific Sessions taking place November 7-11, 2015 in Orlando, FL.

EPA Therapy Added to Statin Therapy Showed Coronary Plaque Regression at Approximately Twice the Prevalence Compared to Statin Therapy Alone in Japanese Clinical Study

Diadexus, Inc. and OriGene Technologies Sign Exclusive License Agreement for the Development and Commercialization of PLAC(R) ELISA in Asia
Diadexus, Inc. (OTCQB: DDXS), a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, today announced that it has entered into an exclusive, license and supply agreement granting OriGene Technologies, Inc. ("OriGene") rights to develop and commercialize Diadexus' proprietary PLAC® ELISA in certain Asian countries ("the Territory").

First Amendment Decision a Win for Amarin and Physician Plaintiffs

Diadexus and Mayo Clinic Join Forces on PLAC Activity Test to Improve Patient Care for Cardiovascular Diseases
Diadexus, Inc. (OTCQB: DDXS), a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, and Mayo Clinic recently signed an agreement to collaborate in the areas of education, research, and innovation on the PLAC® Test for Lp-PLA2 Activity. The test, which has been cleared by the U.S

PatientPerspectives.org Explains How Erectile Dysfunction Can Be a Warning Sign for Serious Underlying Conditions
Erectile dysfunction (ED), while most common among men over 50, should not be written off as just an inevitable part of aging. Current medical opinion is that all men suffering with ED should have a health assessment to find a potential underlying cause. Patientperspectives

Statins Inhibit Vitamin K2 and Stimulate Hardening of the Arteries: NattoPharma Highlights New Review Paper
Few consumers read Expert Review Clinical Pharmacology, but NattoPharma, makers of MenaQ7™ Vitamin K2 as MK-7, feels a new paper published in the March issue should be part of doctors' conversations with their patients before they prescribe a statin therapy

Diadexus, Inc. Announces Presentation of Results From the PLAC(R) Activity Test Clinical Validation Study
Diadexus, Inc

National Panel of Multidisciplinary Experts Addresses the Unmet Needs in Assessing Coronary Artery Disease in Women
CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the publication of "The Diagnosis of CAD in Women: Addressing the Unmet Need," a summary report synthesizing discussion from a roundtable meeting of experts organized by the Jefferson School of Population Health (JSPH) in partnership with the Society for Women's Health Research (SWHR)

Diadexus, Inc. Highlights Upcoming Oral Presentation of Data From the PLAC(R) Activity Test Validation Study at the EAS Meeting
Diadexus, Inc

diaDexus, Inc. to Report Fourth Quarter and Full Year 2014 Financial Results on March 11, 2015
diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that it will report fourth quarter and full year 2014 financial results on Wednesday, March 11, 2015 after market close, and will host a conference call to discuss financial results and provide a business update at 4:30 p.m. ET (1:30 p.m

diaDexus, Inc. Announces Appointment of Leone Patterson as Chief Financial Officer
diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced the appointment of Leone Patterson as chief financial officer.

diaDexus, Inc. Announces Appointment of John Curnutte, M.D., Ph.D. to Its Board of Directors
diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced the appointment of John Curnutte, M.D., Ph.D. as an independent member of its board of directors effective immediately. Dr. Curnutte will serve on the compensation committee. The Company also announced that Adeoye (Oye) Olukotun, M.D

diaDexus, Inc. Appoints Mika Newton to Lead Clinical Development Service Business
diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced the appointment of Mika Newton as general manager of the clinical development services business unit to partner with pharmaceutical companies interested in using the Company's proprietary cardiac biomarkers in their clinical development programs.

Merry Maids Inspires Americans to Get Their Blood Pumping and Their Hearts Healthy With a Push of a Vacuum
MEMPHIS, TN--(Marketwired - January 21, 2015) - This February, Merry Maids, the nation's leading home cleaning company and part of the ServiceMaster (NYSE: SERV) family of brands, is encouraging consumers to "get moving, start cleaning and be heart healthy" by showing some love to their homes and to themselves through the physical activity of cleaning

Good Oral Health Care Can Lead to Better Management of Diabetes
PHOENIX, AZ--(Marketwired - January 19, 2015) - Jeanne Eder Rhodes didn't realize how the simple acts of regularly brushing and flossing her teeth could lead to better health for diabetics. Rhodes, 66, who recently retired as head of the University of Alaska's history department, was diagnosed with type 2 diabetes in 1998.

diaDexus, Inc. Announces Appointment of James Sulat and Elizabeth Hutt to Its Board of Directors
diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced the appointment of James Sulat and Elizabeth Hutt as members of its board of directors effective immediately. Mr. Sulat will serve as chairman of the audit committee and will serve on the nominating and corporate governance committee. Ms

diaDexus, Inc. Updates on 2014 Achievements and 2015 Initiatives
diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today highlighted recent achievements and provided an outlook for its business and initiatives in 2015.

Dalmia to be Convenor of Canola Council
Business Wire IndiaAt the annual meeting of Canola Council of India (a unit of Forum of Indian Food Importers – FIFI) its Core Team was announced as Mr. Pankaj Singhal, Convenor, FIFI; Mr. VN Dalmia, Chairman, Dalmia Continental Pvt. Ltd.; Mr. Ravinder Pal Singh Kohli, Director, Jivo Wellness Pvt. Ltd.; Mr. Amit Lohani, Founder Director, FIFI and Mr

Cranberry Juice May Help Protect Against Heart Disease and Diabetes Risk Factors
Business Wire IndiaA new study1 reveals that drinking low-calorie cranberry juice cocktail may help lower the risk of chronic diseases that rank among the leading causes of death worldwide, including heart disease, diabetes and stroke. The finding is welcome news considering the World Health Organization estimates the trio of diseases annually claim 15

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

Complete Nutrition for Women
(Family Features) With so many different choices in the vitamin aisle, many women find it difficult to choose the right ones to fit their personal needs.

International Olive Council: Global Olive Oil Production and Consumption on the Rise

MSD to Present New Clinical Data on Sitagliptin, Investigational Omarigliptin, and Real-World Data in Patients with Type 2 Diabetes at the 74th Scientific Sessions of the American Diabetes Association

Tree Nut Consumption Associated with Reduced Total and Cause-Specific Mortality
In a study published November 20, 2013 in the New England Journal of Medicine1, researchers looked at the association of nut consumption with total and cause-specific mortality among 76,464 women in the Nurses’ Health Study and 42,498 men in the Health Professionals Follow-up Study

New poll highlights treatment priorities of European primary care physicians when managing Type 2 Diabetes
Ex -US & Ex- UK Medical Media Only

New findings from two studies support substantial benefit of Pradaxa® for prevention of recurrent deep vein thrombosis and pulmonary embolism
For Non-US, Non-UK & Non-Canadian Media Only

Tree Nut Consumption Associated With Reduced Total and Cause-Specific Mortality
FRESNO, CA--(Marketwired - December 19, 2013) - In a study published November 20, 2013 in the New England Journal of Medicine[1], researchers looked at the association of nut consumption with total and cause-specific mortality among 76,464 women in the Nurses' Health Study and 42,498 men in the Health Professionals Follow-up Study

LA County Urges LGBT Community to 'Break Up With Tobacco' in New Anti-Smoking Campaign
The Los Angeles County Department of Public Health today launched an unprecedented new anti-smoking campaign aimed at the lesbian, gay, bisexual and transgender (LGBT) community. The lesbian, gay and bisexual (LGB) populations in California smoke at more than twice the rate of the heterosexual population.

NorthShore University HealthSystem Partners With Mayo Clinic to Study Genomics of Antiplatelet Heart Medication
EVANSTON, IL--(Marketwired - November 19, 2013) - Which antiplatelet medication is best after a coronary stent? The costly and potential life-or-death question lingers after most of the 600,000 angioplasties performed every year in the United States. The answer may lie in your genes, but professional cardiovascular societies and many working cardiologists question the U.S

Impact of Active Biotech's candidate drug tasquinimod on bone metastases presented at ASCO
Tasquinimod Phase II retrospective follow-up study shows an impact of tasquinimod on bone metastases as measured by Bone Scan Index (BSI)

CoreSource Introduces Enhanced Member Health Portal, Powered by HealthFitness
CoreSource, a leading national provider of benefit administration and health management services for self-funded employee benefit plans, announced today that its plan members across the country have access to an enhanced version of its integrated online consumer health portal -- the HealthCenter, now powered by HealthFitness, an affiliate of CoreSource.

Stent Market to Recover With New Product Introductions: Reports Kalorama
The global market for coronary stents is projected to recover from its recent decline due to new product innovations, exceeding $6 billion by 2017, according to a recent report from healthcare market research publisher Kalorama Information

Stents Market Tops $5 Billion, Led by Drug-Eluting Devices
A growing acceptance of drug-eluting stents as a more effective treatment for coronary heart disease, along with increasing awareness about coronary stents among patients, is expected to boost procedural volumes

Celebrate National Apple Month With Tree Top
Did you know October is National Apple Month? While apples are a part of many people's daily lives, they may not know much about the ever-famous fruit.

Saint Joseph Hospital Sponsors a Night of Dancing With Health Education, Screenings, Refreshments and More
Dancing is good for the heart! During American Heart Month in February, Saint Joseph Hospital is sponsoring Day of Dance -- an event that promotes good cardiovascular health -- from 6 to 9 p.m. on Feb. 29 at Park West, 322 W. Armitage Ave., Chicago.

Safety and Efficacy of Pradaxa® (dabigatran etexilate) Reconfirmed in Clinical Setting for VTE Prevention After Total Knee or Hip Replacement
New real-world data reinforces the positive safety and efficacy profile of Pradaxa® (dabigatran etexilate) in clinical practice for the prevention of venous thromboembolism (VTE) in patients undergoing total knee or hip replacement

NCC Cadets take pledge for a healthy heart on the World Heart Day
3000 NCC cadets across India spread the message of a healthy heart in association with Billion Hearts Beating Foundation

Sage Stallone died of heart attack says his toxicology report
Sage Stallone suffered from a coronary heart disease which was caused by atherosclerosis

Why fried food is not always bad for you
The amount of oil consumed makes absolutely no difference on the incidence of heart disease, a new study has claimed.

Omega-3 supplements lower inflammation in overweight older people
Researchers have found that omega-3 fatty acid supplements can lower inflammation in healthy, but overweight, middle-aged and older adults, suggesting that regular use of these supplements could help protect against and treat certain illnesses.

Excessive endurance exercise may cause cardiovascular injury
Regular exercise is highly effective for the prevention and treatment of many common chronic diseases, and improves cardiovascular health and longevity.

Some 'good' cholesterol may up heart disease risk
A subclass of high-density lipoprotein (HDL) cholesterol, the so-called "good" cholesterol, may not protect against coronary heart disease (CHD) and in fact may be harmful, a new study has revealed.

Modest alcohol consumption 'halves risk and severity of hepatitis'
People with nonalcoholic fatty liver disease (NALFD) who consume alcohol in modest amounts, no more than one or two servings per day, are half as likely to develop hepatitis as non-drinkers with the same condition, a new study has claimed.

Opium use may double death risk
Long term opium use, even in relatively low doses, may almost double the risk of death from many causes, particularly circulatory diseases, respiratory conditions and cancer, a new study has suggested.

Arthritis pill could hold key to beating heart disease
Researchers have found that inflammation plays a major role in the development of coronary heart disease.

Dark meat of poultry cuts heart disease risk in women with high cholesterol
A nutrient found in the dark meat of poultry and some seafood may provide protection against coronary heart disease (CHD) in women with high cholesterol, say researchers.

Natural and industrial trans fats' implications on health revealed
In a new study, scientists have given new insights into the health implications of different types of trans fat.

Chinese herbal extract may help curb binge drinking
An extract of the Chinese herb kudzu dramatically reduces drinking and may be useful in the treatment of alcoholism and curbing binge drinking.

Cardiovascular disease risk due to high normal BP 'decreases in old age'
High normal blood pressure becomes less of a risk factor for incident cardiovascular disease (CVD) and coronary heart disease (CHD) with age, a new study has revealed.

Omega-3 fatty acids 'may help reduce physical harm caused by smoking'
Intake of Omega-3 fatty acids may help to reduce the physical damage that is caused by smoking, a new study has revealed.

Diet experts warn Indians to stop increased consumption of junk food
Diet experts have said Indians are consuming junk foods more often than in the past, and have warned that this poses a major risk to their health.

Cytori Completes IDE Filing for Chronic Myocardial Ischemia ATHENA Trial of the Celution(R) System
Cytori Therapeutics (NASDAQ: CYTX) filed its Investigational Device Exemption (IDE) application to begin a clinical trial of the Company's Celution® System for chronic myocardial ischemia (CMI).

Tasly Pharmaceuticals Selects ICON as it Seeks First FDA Approval of a Traditional Chinese Medicine
ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals ( 600535, SH)for the company’s global Phase III T89 trial

TV viewing poses greater risk for heart disease than computer use
A recent study has revealed that different kinds of sedentary activities may have different consequences on children's health, and high levels of TV viewing posses higher cardio-metabolic risk than high computer use.

High blood pressure robs sufferers of 'emotional understanding'
People with higher blood pressure have a reduced ability to recognise angry, fearful, sad and happy faces and text passages, a new study has found.

Soy protein reduces progression of clogged arteries in menopausal women
A new study has found that soy protein reduces the progression of clogged arteries in women who were within five years of menopause.

Over 20 new gene targets to treat high BP identified
Researchers have tracked down more than 20 new gene regions that play an important role in the risk of having high blood pressure.

Coronary heart disease transferred via genes, not family lifestyle
A new study from the Centre for Primary Health Care Research in Sweden has revealed that the risk of coronary heart disease is transferred through the genes and not through an unhealthy lifestyle in the family.

Alcohol intake slashes risk of coronary heart disease
Alcohol intake may slash the risk of death from coronary heart disease and it may not be essentially due to increase in HDL-cholesterol, a new study has suggested.

Soy protein better than milk counterpart for improving cholesterol health
A new study has revealed that supplements of soy protein are much better than milk protein in terms of improving blood levels of HDL (good) cholesterol and thus the overall lipid profile in healthy individuals.

12million people worldwide diagnosed with cancer each year
The number of new cancer cases has soared by a fifth in less than a decade and now stands at 12 million a year, according to new figures.

Comment on this story

Share